Contact Dermatitis: A Practice Parameter-Update 2015

Journal of Allergy and Clinical Immunology: In Practice

Volumn 3, Issue 3, 2015, Pages S1-S39

  Fonacier, Luz ^a   Bernstein, David I ^b   Pacheco, Karin ^c   Holness, D Linn ^d   Blessing Moore, Joann ^e   Khan, David ^f   Lang, David ^g,h   Nicklas, Richard ⁱ   Oppenheimer, John ^j   Portnoy, Jay ^k,l   Randolph, Christopher ^m   Schuller, Diane ⁿ   Spector, Sheldon ^o   Tilles, Stephen ^p   Wallace, Dana ^q  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g Respiratory Institute   (United States)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^j Pulmonary and Allergy Associates PA   (United States)

^k Children's Mercy Hospital   (United States)

^l UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^m Center for Allergy Asthma Immunology   (United States)

ⁿ PENNSYLVANIA STATE UNIVERSITY   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^q affiliation with Nova Southeastern College of Osteopathic Medicine   (United States)

more..

Author keywords

Allergen; Allergic contact dermatitis; Contact dermatitis; Guideline; Occupational; Parameter; Patch testing; Sensitizer

Indexed keywords

CONTACT ALLERGEN;

ARTICLE; ATOPIC DERMATITIS; AVOIDANCE BEHAVIOR; CAUSAL ATTRIBUTION; CHEILITIS; CHILD CARE; CLINICAL EVALUATION; CONTACT DERMATITIS; CONTACT SENSITIZATION; DELAYED HYPERSENSITIVITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FACE RASH; HAND ECZEMA; HOME ENVIRONMENT; HUMAN; HYGIENE PRODUCT; MANAGED CARE; MEDICAL PRACTICE; OCCUPATIONAL ECZEMA; PATCH TEST; PATIENT ASSESSMENT; PERIORAL DERMATITIS; PERSONAL HYGIENE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PROGNOSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SKIN ALLERGY; SKIN EXAMINATION; TOPICAL TREATMENT; ULTRAVIOLET RADIATION; WORKPLACE; DERMATITIS, CONTACT; IMMUNOLOGY; SKIN TEST;

DERMATITIS, CONTACT; HUMANS; SKIN TESTS;

EID: 84929177043     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2015.02.009     Document Type: Article

References (282)

1. Velykoredko Y., Houle M.C., Skotnicki S. Contact dermatitis mimickers: a tertiary care center's experience. JCutan Med Surg 2013, 17:429-432. (III).
2. Rietschel R.L. Clues to an accurate diagnosis of contact dermatitis. Dermatol Ther 2004, 17:224-230. (IV).
3. Josefson A., Farm G., Meding B. Validity of self-reported nickel allergy. Contact Dermatitis 2010, 62:289-293. (IIb).
4. Marks J.G., Belsito D.V., DeLeo V.A., Fowler J.F., Fransway A.F., Maibach H.I., et al. North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens. JAm Acad Dermatol 1998, 38(Pt 1):911-918. (III).
5. Marks J.G., Belsito D.V., DeLeo V.A., Fowler J.F., Fransway A.F., Maibach H.I., et al. North American Contact Dermatitis Group patch-test results, 1998 to 2000. Am J Contact Dermat 2003, 14:59-62. (III).
6. Pratt M.D., Belsito D.V., DeLeo V.A., Fowler J.F., Fransway A.F., Maibach H.I., et al. North American Contact Dermatitis Group patch-test results, 2001-2002 study period. Dermatitis 2004, 15:176-183. (III).
7. Britton J.E., Wilkinson S.M., English J.S., Gawkrodger D.J., Ormerod A.D., Sansom J.E., et al. The British standard series of contact dermatitis allergens: validation in clinical practice and value for clinical governance. Br J Dermatol 2003, 148:259-264. (III).
8. Jain V.K., Aggarwal K., Passi S., Gupta S. Role of contact allergens in pompholyx. JDermatol 2004, 31:188-193. (III).
9. Zelickson B.D., McEvoy M.T., Fransway A.F. Patch testing in prurigo nodularis. Contact Dermatitis 1989, 20:321-325. (III).
10. Clayton T.H., Wilkinson S.M., Rawcliffe C., Pollock B., Clark S.M. Allergic contact dermatitis in children: should pattern of dermatitis determine referral? A retrospective study of 500 children tested between 1995 and 2004 in one U.K. centre. Br J Dermatol 2006, 154:114-117. (III).
11. Bohm I., Brody M., Bauer R. Comparison of personal history with patch test results in metal allergy. JDermatol 1997, 24:510-513. (III).
12. Zug K.A., Rietschel R.L., Warshaw E.M., Belsito D.V., Taylor J.S., Maibach H.I., et al. The value of patch testing patients with a scattered generalized distribution of dermatitis: retrospective cross-sectional analyses of North American Contact Dermatitis Group data, 2001 to 2004. JAm Acad Dermatol 2008, 59:426-431. (III).
13. Lee T.Y., Lam T.H. Patch testing of 490 patients in Hong Kong. Contact Dermatitis 1996, 35:23-26. (III).
14. Usmani N., Wilkinson S.M. Allergic skin disease: investigation of both immediate- and delayed-type hypersensitivity is essential. Clin Exp Allergy 2007, 37:1541-1546. (III).
15. Agrup G. Sensitization induced by patch testing. Br J Dermatol 1968, 80:631-634. (III).
16. Yoshifuku A., Kawai K., Saruwatari H., Higashi Y., Kanekura T. Active sensitization to beryllium by diagnostic patch tests. JDermatol 2012, 39:1084-1085. (IV).
17. Devos S.A., Van Der Valk P.G. Epicutaneous patch testing. Eur J Dermatol 2002, 12:506-513. (IV).
18. Rajagopalan R., Anderson R. Impact of patch testing on dermatology-specific quality of life in patients with allergic contact dermatitis. Am J Contact Dermat 1997, 8:215-221. (III).
19. Mirabelli M.C., Vizcaya D., Marti Margarit A., Anto J.M., Arjona L., Barreiro E., et al. Occupational risk factors for hand dermatitis among professional cleaners in Spain. Contact Dermatitis 2012, 66:188-196. (III).
20. Lazzarini R., Duarte I.A., Sumita J.M., Minnicelli R. Allergic contact dermatitis among construction workers detected in a clinic that did not specialize in occupational dermatitis. An Bras Dermatol 2012, 87:567-571. (III).
21. Lan C.C., Tu H.P., Lee C.H., Wu C.S., Ko Y.C., Yu H.S., et al. Hand dermatitis among university hospital nursing staff with or without atopic eczema: assessment of risk factors. Contact Dermatitis 2011, 64:73-79. (III).
22. Keegel T., Saunders H., LaMontagne A.D., Nixon R. Are material safety data sheets (MSDS) useful in the diagnosis and management of occupational contact dermatitis?. Contact Dermatitis 2007, 57:331-336.
23. Pedersen L.K., Johansen J.D., Held E., Agner T. Augmentation of skin response by exposure to a combination of allergens and irritants-a review. Contact Dermatitis 2004, 50:265-273. (III).
24. Belsito D.V., Fransway A.F., Fowler J.F., Sherertz E.F., Maibach H.I., Mark J.G., et al. Allergic contact dermatitis to detergents: a multicenter study to assess prevalence. JAm Acad Dermatol 2002, 46:200-206.
25. Proksch E., Brasch J. Abnormal epidermal barrier in the pathogenesis of contact dermatitis. Clin Dermatol 2012, 30:335-344. (IV).
26. Warshaw E.M., Belsito D.V., Taylor J.S., Sasseville D., Dekoven J.G., Zirwas M.J., et al. North American Contact Dermatitis Group Patch Test Results: 2009 to 2010. Dermatitis 2013, 24:50-59. (III).
27. Toledo F., Garcia-Bravo B., Fernandez-Redondo V., De la Cuadra J., Gimenez-Arnau A.M., Borrego L., et al. Patch testing in children with hand eczema. A 5-year multicentre study in Spain. Contact Dermatitis 2011, 65:213-219.
28. Feser A., Plaza T., Vogelgsang L., Mahler V. Periorbital dermatitis-a recalcitrant disease: causes and differential diagnoses. Br J Dermatol 2008, 159:858-863. (III).
29. Gordon L.A. Compositae dermatitis. Aust J Dermatol 1999, 40:123-128. (IV).
30. Temesvari E., Ponyai G., Nemeth I., Hidvegi B., Sas A., Karpati S. Periocular dermatitis: a report of 401 patients. JEur Acad Dermatol Venereol 2009, 23:124-128.
31. Novitskaya E.S., Dean S.J., Craig J.P., Alexandroff A.B. Current dilemmas and controversies in allergic contact dermatitis to ophthalmic medications. Clin Dermatol 2011, 29:295-299. (IV).
32. Landeck L., Schalock P.C., Baden L.A., Gonzalez E. Periorbital contact sensitization. Am J Ophthalmol 2010, 150:366-370 e2. (III).
33. Guin J.D. Eyelid dermatitis: a report of 215 patients. Contact Dermatitis 2004, 50:87-90. (III).
34. Zug K.A., Kornik R., Belsito D.V., DeLeo V.A., Fowler J.F., Maibach H.I., et al. Patch-testing North American lip dermatitis patients: data from the NorthAmerican Contact Dermatitis Group, 2001 to 2004. Dermatitis 2008, 19:202-208. (III).
35. Lim S.W., Goh C.L. Epidemiology of eczematous cheilitis at a tertiary dermatological referral centre in Singapore. Contact Dermatitis 2000, 43:322-326. (III).
36. Francalanci S., Sertoli A., Giorgini S., Pigatto P., Santucci B., Valsecchi R. Multicentre study of allergic contact cheilitis from toothpastes. Contact Dermatitis 2000, 43:216-222. (III).
37. Tran A., Pratt M., DeKoven J. Acute allergic contact dermatitis of the lips from peppermint oil in a lip balm. Dermatitis 2010, 21:111-115. (III).
38. Kirshen C., Pratt M. Dental allergic contact dermatitis: an interesting case series and review of the literature. Dermatitis 2012, 23:222-226. (III).
39. Torgerson R.R., Davis M.D., Bruce A.J., Farmer S.A., Rogers R.S. Contact allergy in oral disease. JAm Acad Dermatol 2007, 57:315-321. (III).
40. Carlsen B.C., Menne T., Johansen J.D. 20 Years of standard patch testing in an eczema population with focus on patients with multiple contact allergies. Contact Dermatitis 2007, 57:76-83. (III).
41. Dotterud L.K. The prevalence of allergic contact sensitization in a general population in Tromso, Norway. Int J Circumpolar Health 2007, 66:328-334. (III).
42. Warshaw E.M., Buchholz H.J., Belsito D.V., Maibach H.I., Fowler J.F., Rietschel R.L., et al. Allergic patch test reactions associated with cosmetics: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001-2004. JAm Acad Dermatol 2009, 60:23-38. (III).
43. Yazar K., Boman A., Liden C. p-Phenylenediamine and other hair dye sensitizers in Spain. Contact Dermatitis 2012, 66:27-32. (III).
44. Zirwas M., Moennich J. Shampoos. Dermatitis 2009, 20:106-110.
45. Hillen U., Grabbe S., Uter W. Patch test results in patients with scalp dermatitis: analysis of data of the Information Network of Departments of Dermatology. Contact Dermatitis 2007, 56:87-93. (III).
46. Johansen J.D., Hald M., Andersen B.L., Laurberg G., Danielsen A., Avnstorp C., et al. Classification of hand eczema: clinical and aetiological types. Based on the guideline of the Danish Contact Dermatitis Group. Contact Dermatitis 2011, 65:13-21.
47. Klaschka U. Contact allergens for armpits-allergenic fragrances specified on deodorants. Int J Hyg Environ Health 2012, 215:584-591. (III).
48. Jorgensen P.H., Jensen C.D., Rastogi S., Andersen K.E., Johansen J.D. Experimental elicitation with hydroxyisohexyl-3-cyclohexene carboxaldehyde-containing deodorants. Contact Dermatitis 2007, 56:146-150. (IIa).
49. Svedman C., Bruze M., Johansen J.D., Andersen K.E., Goossens A., Frosch P.J., et al. Deodorants: an experimental provocation study with hydroxycitronellal. Contact Dermatitis 2003, 48:217-223. (IIa).
50. Sheu M., Simpson E.L., Law S.V., Storrs F.J. Allergic contact dermatitis from a natural deodorant: a report of 4 cases associated with lichen acid mix allergy. JAm Acad Dermatol 2006, 55:332-337. (III).
51. Bruze M., Johansen J.D., Andersen K.E., Frosch P., Goossens A., Lepoittevin J.P., et al. Deodorants: an experimental provocation study with isoeugenol. Contact Dermatitis 2005, 52:260-267.
52. Bruze M., Johansen J.D., Andersen K.E., Frosch P., Lepoittevin J.P., Rastogi S., et al. Deodorants: an experimental provocation study with cinnamic aldehyde. JAm Acad Dermatol 2003, 48:194-200. (IIb).
53. Gall H., Kempf E. Contact allergy due to the topical antiperspirant propantheline bromide (author's transl). Derm Beruf Umwelt 1982, 30:55-56. 7 (III).
54. Przybilla B., Schwab U., Holzle E., Ring J. Contact sensitization to an antiperspirant with the active ingredient propantheline bromide. Hautarzt 1983, 34:459-462.
55. Giusti F., Massone F., Bertoni L., Pellacani G., Seidenari S. Contact sensitization to disperse dyes in children. Pediatr Dermatol 2003, 20:393-397. (III).
56. Wentworth A.B., Richardson D.M., Davis M.D. Patch testing with textile allergens: the mayo clinic experience. Dermatitis 2012, 23:269-274. (III).
57. Ryberg K., Isaksson M., Gruvberger B., Hindsen M., Zimerson E., Bruze M. Contact allergy to textile dyes in southern Sweden. Contact Dermatitis 2006, 54:313-321. (III).
58. Winnicki M., Shear N.H. Asystematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions. Am J Clin Dermatol 2011, 12:171-180. (IV).
59. Warshaw E.M., Furda L.M., Maibach H.I., Rietschel R.L., Fowler J.F., Belsito D.V., et al. Anogenital dermatitis in patients referred for patch testing: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 1994-2004. ArchDermatol 2008, 144:749-755.
60. Bauer A., Geier J., Elsner P. Allergic contact dermatitis in patients with anogenital complaints. JReproduct Med 2000, 45:649-654. (III).
61. Chang M.W., Nakrani R. Six children with allergic contact dermatitis to methylisothiazolinone in wet wipes (baby wipes). Pediatrics 2014, 133:e434-e438. (III).
62. Theler B., Bucher C., French L.E., Ballmer Weber B., Hofbauer G.F. Clinical expression of nickel contact dermatitis primed by diagnostic patch test. Dermatology 2009, 219:73-76. (IIb).
63. Corazza M., Mantovani L., Montanari A., Virgili A. Allergic contact dermatitis from transdermal estradiol and systemic contact dermatitis from oral estradiol. A case report. JReproduct Med 2002, 47:507-509. (III).
64. Isaksson M., Bruze M. Allergic contact dermatitis in response to budesonide reactivated by inhalation of the allergen. JAm Acad Dermatol 2002, 46:880-885. (III).
65. Landeck L., Uter W., John S.M. Patch test characteristics of patients referred for suspected contact allergy of the feet-retrospective 10-year cross-sectional study of the IVDK data. Contact Dermatitis 2012, 66:271-278.
66. Warshaw E.M., Schram S.E., Belsito D.V., DeLeo V.A., Fowler J.F., Maibach H.I., et al. Shoe allergens: retrospective analysis of cross-sectional data from the North American contact dermatitis group, 2001-2004. Dermatitis 2007, 18:191-202. (III).
67. Warshaw E.M., Cook J.W., Belsito D.V., DeLeo V.A., Fowler J.F., Maibach H.I., et al. Positive patch-test reactions to mixed dialkyl thioureas: cross-sectional data from the North American Contact Dermatitis Group, 1994 to 2004. Dermatitis 2008, 19:190-201. (III).
68. Darling M.I., Horn H.M., McCormack S.K., Schofield O.M. Sole dermatitis in children: patch testing revisited. Pediatric Dermatol 2012, 29:254-257. (III).
69. Smart V., Alavi A., Coutts P., Fierheller M., Coelho S., Linn Holness D., et al. Contact allergens in persons with leg ulcers: a Canadian study in contact sensitization. Int J Low Extrem Wounds 2008, 7:120-125. (III).
70. Barbaud A., Collet E., Le Coz C.J., Meaume S., Gillois P. Contact allergy in chronic leg ulcers: results of a multicentre study carried out in 423 patients and proposal for an updated series of patch tests. Contact Dermatitis 2009, 60:279-287. (III).
71. Carlsen B.C., Andersen K.E., Menne T., Johansen J.D. Sites of dermatitis in a patch test population: hand dermatitis is associated with polysensitization. Br J Dermatol 2009, 161:808-813. (IIa).
72. Renner R., Simon J.C., Treudler R. Contact sensitization to modern wound dressings in 70 patients with chronic leg ulcers. Dermatitis 2013, 24:60-63. (IIb).
73. Thyssen J.P., Linneberg A., Engkilde K., Menne T., Johansen J.D. Contact sensitization to common haptens is associated with atopic dermatitis: new insight. Br J Dermatol 2012, 166:1255-1261. (III).
74. Zug K.A., McGinley-Smith D., Warshaw E.M., Taylor J.S., Rietschel R.L., Maibach H.I., et al. Contact allergy in children referred for patch testing: North American Contact Dermatitis Group data, 2001-2004. Arch Dermatol 2008, 144:1329-1336. (III).
75. Thyssen J.P., Linneberg A., Ross-Hansen K., Carlsen B.C., Meldgaard M., Szecsi P.B., et al. Filaggrin mutations are strongly associated with contactsensitization in individuals with dermatitis. Contact Dermatitis 2013, 68:273-276. (III).
76. Malajian D., Belsito D.V. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis. JAm Acad Dermatol 2013, 69:232-237.
77. Jacob S.E., Brod B., Crawford G.H. Clinically relevant patch test reactions in children-a United States based study. Pediatric Dermatol 2008, 25:520-527. (III).
78. Anveden I., Lindberg M., Andersen K.E., Bruze M., Isaksson M., Liden C., et al. Oral prednisone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickel. Contact Dermatitis 2004, 50:298-303. (Ib).
79. Rosmarin D., Gottlieb A.B., Asarch A., Scheinman P.L. Patch-testing while on systemic immunosuppressants. Dermatitis 2009, 20:265-270. (III).
80. Wee J.S., White J.M., McFadden J.P., White I.R. Patch testing in patients treated with systemic immunosuppression and cytokine inhibitors. Contact Dermatitis 2010, 62:165-169. (III).
81. Green C. The effect of topically applied corticosteroid on irritant and allergic patch test reactions. Contact Dermatitis 1996, 35:331-333. (IIb).
82. Prens E.P., Benne K., Geursen-Reitsma A.M., van Dijk G., Benner R., van Joost T. Effects of topically applied glucocorticosteroids on patch test responses and recruitment of inflammatory cells in allergic contact dermatitis. Agents Actions 1989, 26:125-127. (IIb).
83. Aldridge R.D., Sewell H.F., King G., Thomson A.W. Topical cyclosporin A in nickel contact hypersensitivity: results of a preliminary clinical and immunohistochemical investigation. Clin Exp Immunol 1986, 66:582-589. (IIb).
84. Alomar A., Puig L., Gallardo C.M., Valenzuela N. Topical tacrolimus 0.1% ointment (protopic) reverses nickel contact dermatitis elicited by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema. Contact Dermatitis 2003, 49:185-188. (Ib).
85. Damian D.L., Halliday G.M. Measurement of ultraviolet radiation-induced suppression of recall contact and delayed-type hypersensitivity in humans. Methods 2002, 28:34-45. (IV).
86. Damian D.L., Halliday G.M., Barnetson R.S. Broad-spectrum sunscreens provide greater protection against ultraviolet-radiation-induced suppression of contact hypersensitivity to a recall antigen in humans. JInvest Dermatol 1997, 109:146-151. (IIa).
87. Chen X.J., Chen L.L., Shi X., Xie L.X., Leng H., Ji J., et al. The effect of desloratadine on patch test reactions in Chinese patients. Asian Pac J Allergy Immunol 2012, 30:209-213. (IIb).
88. Zug K.A., Warshaw E.M., Fowler J.F., Maibach H.I., Belsito D.L., Pratt M.D., et al. Patch-test results of the North American Contact Dermatitis Group 2005-2006. Dermatitis 2009, 20:149-160. (III).
89. Ale S.I., Maibach H.I. Reproducibility of patch test results: a concurrent right-versus-left study using TRUE Test. Contact Dermatitis 2004, 50:304-312. (IIb).
90. Goh C.L. Comparative study of TRUE Test and Finn Chamber patch test techniques in Singapore. Contact Dermatitis 1992, 27:84-89. 1992.
91. Wilkinson J.D., Bruynzeel D.P., Ducombs G., Frosch P.J., Gunnarsson Y., Hannuksela M., et al. European multicenter study of TRUE Test, Panel 2. Contact Dermatitis 1990, 22:218-225. (III).
92. Wilkinson D.S., Fregert S., Magnusson B., Bandmann H.J., Calnan C.D., Cronin E., et al. Terminology of contact dermatitis. Acta Derm Venereol 1970, 50:287-292. (IV).
93. 2. Contact Dermatitis 1984, 10:25-29. (III).
94. Davis M.D., Bhate K., Rohlinger A.L., Farmer S.A., Richardson D.M., Weaver A.L. Delayed patch test reading after 5 days: the Mayo Clinic experience. JAm Acad Dermatol 2008, 59:225-233. (III).
95. Jonker M.J., Bruynzeel D.P. The outcome of an additional patch-test reading on days 6 or 7. Contact Dermatitis 2000, 42:330-335.
96. Geier J., Gefeller O., Wiechmann K., Fuchs T. Patch test reactions at D4, D5 and D6. Contact Dermatitis 1999, 40:119-126. (III).
97. Gawkrodger D.J., Paul L. Late patch test reactions: delayed immune response appears to be more common than active sensitization. Contact Dermatitis 2008, 59:185-187. (III).
98. Hillen U., Jappe U., Frosch P.J., Becker D., Brasch J., Lilie M., et al. Late reactions to the patch-test preparations para-phenylenediamine and epoxy resin: a prospective multicentre investigation of the German Contact Dermatitis Research Group. Br J Dermatol 2006, 154:665-670. (IIb).
99. Aalto-Korte K., Alanko K., Kuuliala O., Jolanki R. Late reactions in patch tests: a 4-year review from a clinic of occupational dermatology. Contact Dermatitis 2007, 56:81-86. (III).
100. Flannigan S.A., Smolensky M.H., Harrist R., Machinski G., McGovern J.P. Time considerations in scoring contact irritant patch test sites. Contact Dermatitis 1983, 9:519-520. (IIb).
101. Davis M.D., Scalf L.A., Yiannias J.A., Cheng J.F., El-Azhary R.A., Rohlinger A.L., et al. Changing trends and allergens in the patch test standard series: a mayo clinic 5-year retrospective review, January 1, 2001, through December 31, 2005. Arch Dermatol 2008, 144:67-72.
102. Dickel H., Taylor J.S., Evey P., Merk H.F. Delayed readings of a standard screening patch test tray: frequency of "lost," "found," and "persistent" reactions. Am J Contact Dermatitis 2000, 11:213-217.
103. Carlson S., Gipson K., Nedorost S. Relevance of doubtful ("equivocal") late patch-test readings. Dermatitis 2010, 21:102-108. (III).
104. Duarte I., Lazzarini R., Bedrikow R. Excited skin syndrome: study of 39 patients. Am J Contact Dermat 2002, 13:59-65. (IIb).
105. Lazzarini R., Duarte I., de Farias D.C., Santos C.A., Tsai A.I. Frequency and main sites of allergic contact dermatitis caused by nail varnish. Dermatitis 2008, 19:319-322.
106. Cockayne S.E., Gawkrodger D.J. Angry back syndrome is often due to marginal irritants: a study of 17 cases seen over 4 years. Contact Dermatitis 2000, 43:280-282.
107. White J.M. Patch testing: what allergists should know. Clin Exp Allergy 2012, 42:180-185. (IV).
108. Nethercott J.R., Holness D.L. Disease outcome in workers with occupational skin disease. JAm Acad Dermatol 1994, 30:569-574. (III).
109. Fransway A.F., Zug K.A., Belsito D.V., Deleo V.A., Fowler J.F., Maibach H.I., et al. North American Contact Dermatitis Group patch test results for 2007-2008. Dermatitis 2013, 24:10-21. (III).
110. van der Valk P.G., Devos S.A., Coenraads P.J. Evidence-based diagnosis in patch testing. Contact Dermatitis 2003, 48:121-125. (IV).
111. De Groot A. Test Concentrations and Vehicles for 4350 Chemicals 2008, Wapserveen, The Netherlands: A.C. DeGroot Publishing, (IV). 3rd ed.
112. Mendelow A.Y., Forsyth A., Florence A.T., Baillie A.J. Patch testing for nickel allergy. The influence of the vehicle on the response rate to topical nickel sulphate. Contact Dermatitis 1985, 13:29-33. (IIb).
113. Tanglertsampan C., Maibach H.I. The role of vehicles in diagnostic patch testing. A reappraisal. Contact Dermatitis 1993, 29:169-174. (III).
114. Batchelor R.J., Wilkinson S.M. Photopatch testing-a retrospective review using the 1 day and 2 day irradiation protocols. Contact Dermatitis 2006, 54:75-78. (III).
115. Lachapelle J.M., Maibach H.I. Patch Testing and Prick Testing. A Practical Guide 2009, Berlin, Heidelberg, Springer Verlag, (IV). 2nd ed.
116. Pacheco K., Barker L., Maier L., Erb S., Sills M., Knight V. Development of a validated blood test for nickel sensitization. JAllergy Clin Immunol 2013, 132:767-769. (IIb).
117. Spiewak R., Moed H., von Blomberg B.M., Bruynzeel D.P., Scheper R.J., Gibbs S., et al. Allergic contact dermatitis to nickel: modified in vitro test protocols for better detection of allergen-specific response. Contact Dermatitis 2007, 56:63-69. (IIb).
118. Lindemann M., Rietschel F., Zabel M., Grosse-Wilde H. Detection of chromium allergy by cellular in vitro methods. Clin Exp Allergy 2008, 38:1468-1475. (IIb).
119. Moed H., von Blomberg M., Bruynzeel D.P., Scheper R., Gibbs S., Rustemeyer T. Improved detection of allergen-specific T-cell responses in allergic contact dermatitis through the addition of 'cytokine cocktails'. Exp Dermatol 2005, 14:634-640. (IIb).
120. Kreiss K., Newman L.S., Mroz M.M., Campbell P.A. Screening blood test identifies subclinical beryllium disease. JOccup Med 1989, 31:603-608. (IIb).
121. Fischer L.A., Johansen J.D., Menne T. Nickel allergy: relationship between patch test and repeated open application test thresholds. Br J Dermatol 2007, 157:723-729. (IIb).
122. Zaghi D., Maibach H.I. Quantitative relationships between patch test reactivity and use test reactivity: an overview. Cutan Ocular Toxicol 2008, 27:241-248. (III).
123. Kerschenlohr K., Darsow U., Burgdorf W.H., Ring J., Wollenberg A. Lessons from atopy patch testing in atopic dermatitis. Curr Allergy Asthma Reports 2004, 4:285-289. (IV).
124. Darsow U., Vieluf D., Ring J. The atopy patch test: an increased rate of reactivity in patients who have an air-exposed pattern of atopic eczema. Br J Dermatol 1996, 135:182-186. (IIb).
125. Towers G.H., Mitchell J.C. The current status of the weed Parthenium hysterophorus L. as a cause of allergic contact dermatitis. Contact Dermatitis 1983, 9:465-469. (IV).
126. Sharma V.K., Sethuraman G. Parthenium dermatitis. Dermatitis 2007, 18:183-190. (IV).
127. Yokozeki H., Satoh T., Katayama I., Nishioka K. Airborne contact dermatitis due to Japanese cedar pollen. Contact Dermatitis 2007, 56:224-228. (III).
128. Schumacher M.J., Silvis N.G. Airborne contact dermatitis from Ambrosia deltoidea (triangle-leaf bursage). Contact Dermatitis 2003, 48:212-216. (III).
129. Munoz F.J., Delgado J., Palma J.L., Gimenez M.J., Monteseirin F.J., Conde J. Airborne contact urticaria due to mulberry (Morus alba) pollen. Contact Dermatitis 1995, 32:61. (III).
130. Uter W., Schnuch A., Geier J., Pfahlberg A., Gefeller O. Association between occupation and contact allergy to the fragrance mix: a multifactorial analysis of national surveillance data. Occup Environ Med 2001, 58:392-398.
131. Nethercott J.R., Nield G., Holness D.L. Areview of 79 cases of eyelid dermatitis. JAm Acad Dermatol 1989, 21(Pt 1):223-230. (IIa).
132. Nedorost S., Wagman A. Positive patch-test reactions to gold: patients' perception of relevance and the role of titanium dioxide in cosmetics. Dermatitis 2005, 16:67-70. (III).
133. Johansen J.D., Frosch P.J., Svedman C., Andersen K.E., Bruze M., Pirker C., et al. Hydroxyisohexyl 3-cyclohexene carboxaldehyde- known as Lyral: quantitative aspects and risk assessment of an important fragrance allergen. Contact Dermatitis 2003, 48:310-316. (Ib).
134. Larsen W., Nakayama H., Lindberg M., Fischer T., Elsner P., Burrows D., et al. Fragrance contact dermatitis: a worldwide multicenter investigation (Part I). Am J Contact Dermat 1996, 7:77-83. (IIb).
135. Api A.M. Sensitization methodology and primary prevention of the research institute for fragrance materials. Dermatology 2002, 205:84-87. (III).
136. Naldi L. The epidemiology of fragrance allergy: questions and needs. Dermatology 2002, 205:89-97. (III).
137. Rastogi S.C., Menne T., Johansen J.D. The composition of fine fragrances is changing. Contact Dermatitis 2003, 48:130-132. (IV).
138. Scheinman P.L. The foul side of fragrance-free products: what every clinician should know about managing patients with fragrance allergy. JAm Acad Dermatol 1999, 41:1020-1024. (IV).
139. Johansen J.D. Fragrance contact allergy: a clinical review. Am J Clin Dermatol 2003, 4:789-798. (IV).
140. Heydorn S., Menne T., Andersen K.E., Bruze M., Svedman C., White I.R., et al. Citral a fragrance allergen and irritant. Contact Dermatitis 2003, 49:32-36.
141. Gimenez-Arnau A., Gimenez-Arnau E., Serra-Baldrich E., Lepoittevin J.P., Camarasa J.G. Principles and methodology for identification of fragrance allergens in consumer products. Contact Dermatitis 2002, 47:345-352. (IIb).
142. Wohrl S., Hemmer W., Focke M., Gotz M., Jarisch R. The significance of fragrance mix, balsam of Peru, colophony and propolis as screening tools in the detection of fragrance allergy. Br J Dermatol 2001, 145:268-273. (IIb).
143. Ting P.T., Silver S. Allergic contact dermatitis to propolis. JDrugs Dermatol 2004, 3:685-686. (IV).
144. Wenk K.S., Ehrlich A. Fragrance series testing in eyelid dermatitis. Dermatitis 2012, 23:22-26. (IIb).
145. Schöllnast R., Kränke B., Aberer W. Anal and palmar contact dermatitis caused by iodopropynyl butylcarbamate in moist sanitary wipes. Hautarzt 2003, 54:970-974. (III).
146. Badreshia S., Marks J.G. Iodopropynyl butylcarbamate. Am J Contact Dermat 2002, 13:77-79. (IV).
147. Skinner S.L., Marks J.G. Allergic contact dermatitis to preservatives in topical medicaments. Am J Contact Dermatitis 1998, 9:199-201. (III).
148. Wilkinson J.D., Shaw S., Andersen K.E., Brandao F.M., Bruynzeel D.P., Bruze M., et al. Monitoring levels of preservative sensitivity in Europe. A 10-year overview (1991-2000). Contact Dermatitis 2002, 46:207-210. (III).
149. De Groot A., White I.R., Flyvholm M.A., Lensen G., Coenraads P.J. Formaldehyde-releasers in cosmetics: relationship to formaldehyde contact allergy. Part 2. Patch test relationship to formaldehyde contact allergy, experimental provocation tests, amount of formaldehyde released, and assessment of risk to consumers allergic to formaldehyde. Contact Dermatitis 2010, 62:18-31. (III).
150. De Groot A.C., Flyvholm M.A., Lensen G., Menne T., Coenraads P.J. Formaldehyde-releasers: relationship to formaldehyde contact allergy. Contact allergy to formaldehyde and inventory of formaldehyde-releasers. Contact Dermatitis 2009, 61:63-85. (III).
151. Diepgen T.L., Weisshaar E. Contact dermatitis: epidemiology and frequent sensitizers to cosmetics. JEur Acad Dermatol Venereol 2007, 21(Suppl 2):9-13. (III).
152. Warshaw E.M., Ahmed R.L., Belsito D.V., DeLeo V.A., Fowler J.F., Maibach H.I., et al. Contact dermatitis of the hands: cross-sectional analyses of North American Contact Dermatitis Group Data, 1994-2004. JAm Acad Dermatol 2007, 57:301-314.
153. Bruze M., Dahlquist I., Fregert S., Gruvberger B., Persson K. Contact allergy to the active ingredients of Kathon CG. Contact Dermatitis 1987, 16:183-188. (IIb).
154. Frequency of use of cosmetic ingredients 2007, Administration DFFaD, http://www.fda.gov/cosmetics/registrationprogram/default.htm. Accessed March 31, 2015. (III).
155. Castanedo-Tardana M.P., Zug K.A. Methylisothiazolinone. Dermatitis 2013, 24:2-6. (IV).
156. Lundov M.D., Thyssen J.P., Zachariae C., Johansen J.D. Prevalence and cause of methylisothiazolinone contact allergy. Contact Dermatitis 2010, 63:164-167. (III).
157. Fisher A.A. Paraben dermatitis due to a new medicated bandage: the "paraben paradox". Contact Dermatitis 1979, 5:273-274. (IV).
158. Coutts I., Shaw S., Orton D. Patch testing with pure tea tree oil-12 months experience. Br J Dermatol 2002, 147:67-74.
159. Walgrave S.E., Warshaw E.M., Glesne L.A. Allergic contact dermatitis from propolis. Dermatitis 2005, 16:209-215. (IV).
160. Orton D.I., Wilkinson J.D. Cosmetic allergy: incidence, diagnosis, and management. Am J Clin Dermatol 2004, 5:327-337. (IV).
161. Fowler J.F., Zug K.M., Taylor J.S., Storrs F.J., Sherertz E.A., Sasseville D.A., et al. Allergy to cocamidopropyl betaine and amidoamine in North America. Dermatitis 2004, 15:5-6. (IIa).
162. Kimber I., Quirke S., Cumberbatch M., Ashby J., Paton D., Aldridge R.D., et al. Lymphocyte transformation and thiuram sensitization. Contact Dermatitis 1991, 24:164-171.
163. Fowler J.F., Fowler L.M., Hunter J.E. Allergy to cocamidopropyl betaine may be due to amidoamine: a patch test and product use test study. Contact Dermatitis 1997, 37:276-281. (IIa).
164. Zapolanski T., Jacob S.E. para-Phenylenediamine. Dermatitis 2008, 19:E20-E21. (IV).
165. Krasteva M., Cristaudo A., Hall B., Orton D., Rudzki E., Santucci B., et al. Contact sensitivity to hair dyes can be detected by the consumer open test. Eur J Dermatol 2002, 12:322-326. (IIb).
166. Scheman A., Cha C., Bhinder M. Alternative hair-dye products for persons allergic to para-phenylenediamine. Dermatitis 2011, 22:189-192. (IIb).
167. Schnuch A., Lessmann H., Frosch P.J., Uter W. para-Phenylenediamine: the profile of an important allergen. Results of the IVDK. Br J Dermatol 2008, 159:379-386. (III).
168. Ho S.G., Basketter D.A., Jefferies D., Rycroft R.J., White I.R., McFadden J.P. Analysis of para-phenylenediamine allergic patients in relation to strength of patch test reaction. Br J Dermatol 2005, 153:364-367. (IIb).
169. Storrs F.J. Permanent wave contact dermatitis: contact allergy to glyceryl monothioglycolate. JAm Acad Dermatol 1984, 11:74-85. (III).
170. Stechschulte S.A., Avashia N., Jacob S.E. Tosylamide formaldehyde resin. Dermatitis 2008, 19:E18-E19.
171. Freeman S., Lee M.S., Gudmundsen K. Adverse contact reactions to sculptured acrylic nails: 4 case reports and a literature review. Contact Dermatitis 1995, 33:381-385. (III).
172. Madnani N.A., Khan K.J. Nail cosmetics. Indian J Dermatol. Venereol Leprol 2012, 78:309-317. (IV).
173. Deleo V.A. Photocontact dermatitis. Dermatol Ther 2004, 17:279-288. (IV).
174. Scheuer E., Warshaw E. Sunscreen allergy: a review of epidemiology, clinical characteristics, and responsible allergens. Dermatitis 2006, 17:3-11. (IV).
175. Scheman A. Adverse reactions to cosmetic ingredients. Dermatol Clin 2000, 18:685-698. (IV).
176. Schauder S., Ippen H. Contact and photocontact sensitivity to sunscreens. Review of a 15-year experience and of the literature. Contact Dermatitis 1997, 37:221-232. (IV).
177. Prystowsky S.D., Allen A.M., Smith R.W., Nonomura J.H., Odom R.B., Akers W.A. Allergic contact hypersensitivity to nickel, neomycin, ethylenediamine, and benzocaine. Relationships between age, sex, history of exposure, and reactivity to standard patch tests and use tests in a general population. Arch Dermatol 1979, 115:959-962. (III).
178. Malhotra V., Kaur I., Saraswat A., Kumar B. Frequency of patch-test positivity in patients with psoriasis: a prospective controlled study. Acta Derm Venereol 2002, 82:432-435. (IIb).
179. Antevil J.L., Muldoon M.P., Battaglia M., Green R. Intraoperative anaphylactic shock associated with bacitracin irrigation during revision total knee arthroplasty. A case report. JBone Joint Surg Am 2003, 85-A:339-342. (IV).
180. Smack D.P., Harrington A.C., Dunn C., Howard R.S., Szkutnik A.J., Krivda S.J., et al. Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs bacitracin ointment. A randomized controlled trial. JAMA 1996, 276:972-977. (Ib).
181. Shackelford K.E., Belsito D.V. The etiology of allergic-appearing foot dermatitis: a 5-year retrospective study. JAm Acad Dermat 2002, 47:715-721. (III).
182. Rani Z., Hussain I., Haroon T.S. Common allergens in shoe dermatitis: our experience in Lahore, Pakistan. Int J Dermatol 2003, 42:605-607. (IV).
183. Zmudzinska M., Czarnecka-Operacz M., Silny W. Contact allergy to glucocorticosteroids in patients with chronic venous leg ulcers, atopic dermatitis and contact allergy. Acta Dermatovenerol Croat 2008, 16:72-78. (IIa).
184. Baeck M., Goossens A. Immediate and delayed allergic hypersensitivity to corticosteroids: practical guidelines. Contact Dermatitis 2012, 66:38-45. (IIb).
185. Bennett M.L., Fountain J.M., McCarty M.A., Sherertz E.F. Contact allergy to corticosteroids in patients using inhaled or intranasal corticosteroids for allergic rhinitis or asthma. Am J Contact Dermat 2001, 12:193-196. (III).
186. Isaksson M. Corticosteroids. Dermatol Ther 2004, 17:314-320. (IV).
187. McFadden J. Contact allergic reactions in patients with atopic eczema. Acta Derm Venereol Suppl 2005, 215:28-32.
188. Ferguson A.D., Emerson R.M., English J.S. Cross-reactivity patterns to budesonide. Contact Dermatitis 2002, 47:337-340. (III).
189. Lepoittevin J.P., Drieghe J., Dooms-Goossens A. Studies in patients with corticosteroid contact allergy. Understanding cross-reactivity among different steroids. Arch Dermatol 1995, 131:31-37. (III).
190. Coopman S., Degreef H., Dooms-Goossens A. Identification of cross-reaction patterns in allergic contact dermatitis from topical corticosteroids. Br J Dermatol 1989, 121:27-34. (IIb).
191. Bjarnason B., Flosadottir E., Fischer T. Assessment of budesonide patch tests. Contact Dermatitis 1999, 41:211-217. (IIa).
192. Boffa M.J., Wilkinson S.M., Beck M.H. Screening for corticosteroid contact hypersensitivity. Contact Dermatitis 1995, 33:149-151. (IIa).
193. Jacob S.E., Zapolanski T. Systemic contact dermatitis. Dermatitis 2008, 19:9-15. (IV).
194. Wilkinson S.M. Corticosteroid cross-reactions: an alternative view. Contact Dermatitis 2000, 42:59-63. (IV).
195. Romano A., Viola M., Gaeta F., Rumi G., Maggioletti M. Patch testing in non-immediate drug eruptions. Allergy Asthma Clin Immunol 2008, 4:66-74. (IV).
196. Barbaud A. Skin testing in delayed reactions to drugs. Immunol Allergy Clin North Am 2009, 29:517-535.
197. Barbaud A., Reichert-Penetrat S., Trechot P., Jacquin-Petit M.A., Ehlinger A., Noirez V., et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998, 139:49-58. (IIa).
198. Cham P.M., Warshaw E.M. Patch testing for evaluating drug reactions due to systemic antibiotics. Dermatitis 2007, 18:63-77. (IV).
199. Bruynzeel D.P., de Groot A.C., Weyland J.W. Contact dermatitis to lauryl pyridinium chloride and benzoxonium chloride. Contact Dermatitis 1987, 17:41-42. (IV).
200. Lammintausta K., Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 2005, 152:968-974. (IIa).
201. Barbaud A. Drug patch testing in systemic cutaneous drug allergy. Toxicology 2005, 209:209-216. (IV).
202. Barbaud A., Trechot P., Reichert-Penetrat S., Granel F., Schmutz J.L. The usefulness of patch testing on the previously most severely affected site in a cutaneous adverse drug reaction to tetrazepam. Contact Dermatitis 2001, 44:259-260. (IV).
203. Brockow K., Romano A., Blanca M., Ring J., Pichler W., Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002, 57:45-51.
204. Atanaskova Mesinkovska N., Tellez A., Molina L., Honari G., Sood A., Barsoum W., et al. The effect of patch testing on surgical practices and outcomes in orthopedic patients with metal implants. Arch Dermatol 2012, 148:687-693. (IIb).
205. Schalock P.C., Menne T., Johansen J.D., Taylor J.S., Maibach H.I., Liden C., et al. Hypersensitivity reactions to metallic implants-diagnostic algorithm and suggested patch test series for clinical use. Contact Dermatitis 2011, 66:4-19. (IV).
206. Reed K.B., Davis M.D., Nakamura K., Hanson L., Richardson D.M. Retrospective evaluation of patch testing before or after metal device implantation. Arch Dermatol 2008, 144:999-1007. (III).
207. Krecisz B., Kiec-Swierczynska M., Chomiczewska-Skora D. Allergy to orthopedic metal implants-a prospective study. Int J Occup Med Environ Health 2012, 25:463-469. (III).
208. Thomas P. Patch testing and hypersensitivity reactions to metallic implants: still many open questions. Dermatitis 2013, 24:106-107. (IV).
209. Granchi D., Cenni E., Giunti A., Baldini N. Metal hypersensitivity testing in patients undergoing joint replacement: a systematic review. JBone Joint Surg Br 2012, 94:1126-1134. (Ia).
210. Thyssen J.P., Menne T., Schalock P.C., Taylor J.S., Maibach H.I. Pragmatic approach to the clinical work-up of patients with putative allergic disease to metallic orthopaedic implants before and after surgery. Br J Dermatol 2011, 164:473-478. (IV).
211. Niki Y., Matsumoto H., Otani T., Yatabe T., Kondo M., Yoshimine F., et al. Screening for symptomatic metal sensitivity: a prospective study of 92 patients undergoing total knee arthroplasty. Biomaterials 2005, 26:1019-1026. (III).
212. Andrews I.D., Scheinman P. Systemic hypersensitivity reaction (without cutaneous manifestations) to an implantable cardioverter-defibrillator. Dermatitis 2011, 22:161-164. (III).
213. Kang J., Simpson C.S., Campbell D., Borici-Mazi R., Redfearn D.P., Michael K.A., et al. Cardiac rhythm device contact dermatitis. Ann Noninvasive Electrocardiol 2013, 18:79-83. (III).
214. Jetty P., Jayaram S., Veinot J., Pratt M. Superficial femoral artery nitinol stent in a patient with nickel allergy. JVasc Surg 2013, 58:1388-1390. (III).
215. Khamaysi Z., Bergman R., Weltfriend S. Positive patch test reactions to allergens of the dental series and the relation to the clinical presentations. Contact Dermatitis 2006, 55:216-218. (III).
216. Purello D'Ambrosio F., Ricciardi L., Isola S., Gangemi S., Cilia M., Levanti C., et al. Systemic contact dermatitis to copper-containing IUD. Allergy 1996, 51:658-659. (III).
217. Carlsson A., Moller H. Implantation of orthopaedic devices in patients with metal allergy. Acta Derm Venereol 1989, 69:62-66.
218. Gawkrodger D.J. Nickel sensitivity and the implantation of orthopaedic prostheses. Contact Dermatitis 1993, 28:257-259. (III).
219. Cousen P.J., Gawkrodger D.J. Metal allergy and second-generation metal-on-metal arthroplasties. Contact Dermatitis 2012, 66:55-62. (IV).
220. Thyssen J.P., Engkilde K., Menne T., Johansen J.D., Hansen P.R., Gislason G.H. No association between metal allergy and cardiac in-stent restenosis in patients with dermatitis-results from a linkage study. Contact Dermatitis 2011, 64:138-141. (III).
221. Basko-Plluska J.L., Thyssen J.P., Schalock P.C. Cutaneous and systemic hypersensitivity reactions to metallic implants. Dermatitis 2011, 22:65-79. (IV).
222. Bircher A., Friederich N.F., Seelig W., Scherer K. Allergic complications from orthopaedic joint implants: the role of delayed hypersensitivity to benzoyl peroxide in bone cement. Contact Dermatitis 2012, 66:20-26. (III).
223. Haughton A.M., Belsito D.V. Acrylate allergy induced by acrylic nails resulting in prosthesis failure. JAm Acad Dermatol 2008, 59(Suppl):S123-S124. (III).
224. Lee P.W., Elsaie M.L., Jacob S.E. Allergic contact dermatitis in children: common allergens and treatment: a review. Curr Opin Pediatr 2009, 21:491-498. (IV).
225. Lewis V.J., Statham B.N., Chowdhury M.M. Allergic contact dermatitis in 191 consecutively patch tested children. Contact Dermatitis 2004, 51:155-156. (IIb).
226. Seidenari S., Giusti F., Pepe P., Mantovani L. Contact sensitization in 1094 children undergoing patch testing over a 7-year period. Pediatric Dermatol 2005, 22:1-5. (III).
227. Kutting B., Brehler R., Traupe H. Allergic contact dermatitis in children: strategies of prevention and risk management. Eur J Dermatol 2004, 14:80-85. (IV).
228. Belhadjali H., Giordano-Labadie F., Rance F., Bazex J. "Lucky Luke" contact dermatitis from diapers: a new allergen?. Contact Dermatitis 2001, 44:248. (IV).
229. Weston W.L., Weston J.A., Kinoshita J., Kloepfer S., Carreon L., Toth S., et al. Prevalence of positive epicutaneous tests among infants, children, and adolescents. Pediatrics 1986, 78:1070-1074. (IIa).
230. Fisher A.A. Allergic contact dermatitis in early infancy. Cutis 1994, 54:300-302. (IV).
231. Carder K.R. Hypersensitivity reactions in neonates and infants. Dermatol Ther 2005, 18:160-175. (IV).
232. Worm M., Aberer W., Agathos M., Becker D., Brasch J., Fuchs T., et al. Patch testing in children-recommendations of the German Contact Dermatitis Research Group (DKG). JDtsch Dermatol Ges 2007, 5:107-109. (IV).
233. Jacob S.E., Admani S., Herro E.M. Invited commentary: recommendation for a North American pediatric patch test series. Curr Allergy Asthma Rep 2014, 14:444. (IV).
234. Luckhaupt S.E., Dahlhamer J.M., Ward B.W., Sussell A.L., Sweeney M.H., Sestito J.P., et al. Prevalence of dermatitis in the working population, United States, 2010 National Health Interview Survey. Am J Indus Med 2013, 56:625-634. (IIb).
235. Holness D.L. Recent advances in occupational dermatitis. Curr Opin Allergy Clin Immunol 2013, 13:145-150.
236. Nicholson P.J., Llewellyn D., English J.S. Guidelines Development Group. Evidence-based guidelines for the prevention, identification and management of occupational contact dermatitis and urticaria. Contact Dermatitis 2010, 63:177-186. (IIa).
237. Mathias C.G. Contact dermatitis and workers' compensation: criteria for establishing occupational causation and aggravation. JAm Acad Dermatol 1989, 20(Pt 1):842-848. (IV).
238. Ingber A., Merims S. The validity of the Mathias criteria for establishing occupational causation and aggravation of contact dermatitis. Contact Dermatitis 2004, 51:9-12. (III).
239. Warshaw E.M., Raju S.I., Fowler J.F., Maibach H.I., Belsito D.V., Zug K.A., et al. Positive patch test reactions in older individuals: retrospective analysis from the North American Contact Dermatitis Group, 1994-2008. JAm Acad Dermatol 2012, 66:229-240.
240. Geier J., Lessmann H., Mahler V., Pohrt U., Uter W., Schnuch A. Occupational contact allergy caused by rubber gloves-nothing has changed. Contact Dermatitis 2012, 67:149-156. (IV).
241. Liskowsky J., Geier J., Bauer A. Contact allergy in the cleaning industry: analysis of contact allergy surveillance data of the Information Network of Departments of Dermatology. Contact Dermatitis 2011, 65:159-166. (III).
242. Dever T.T., Walters M., Jacob S. Contact dermatitis in military personnel. Dermatitis 2011, 22:313-319. (III).
243. Guin J.D., Franks H. Fingertip dermatitis in a retail florist. Cutis 2001, 67:328-330. (III).
244. Mascarenhas R., Robalo-Cordeiro M., Fernandes B., Oliveira H.S., Goncalo M., Figueiredo A. Allergic and irritant occupational contact dermatitis from Alstroemeria. Contact Dermatitis 2001, 44:196-197. (III).
245. Gette M.T., Marks J.E. Tulip fingers. Arch Dermatol 1990, 126:203-205. (III).
246. Bruynzeel D.P. Bulb dermatitis. Dermatological problems in the flower bulb industries. Contact Dermatitis 1997, 37:70-77. (IV).
247. El-Azhary R.A., Yiannias J.A. Anew patient education approach in contact allergic dermatitis: the Contact Allergen Replacement Database (CARD). Int J Dermatol 2004, 43:278-280. (IV).
248. Yiannias J.A., Miller R., Kist J.M. Creation, history, and future of the Contact Allergen Replacement Database (CARD). Dermatitis 2009, 20:322-326. (IV).
249. Julander A., Skare L., Vahter M., Liden C. Nickel deposited on the skin-visualization by DMG test. Contact Dermatitis 2011, 64:151-157.
250. Thyssen J.P., Skare L., Lundgren L., Menne T., Johansen J.D., Maibach H.I., et al. Sensitivity and specificity of the nickel spot (dimethylglyoxime) test. Contact Dermatitis 2010, 62:279-288. (IIa).
251. Thyssen J.P., Menne T., Johansen J.D., Liden C., Julander A., Moller P., et al. Aspot test for detection of cobalt release-early experience and findings. Contact Dermatitis 2010, 63:63-69. (IIb).
252. Midander K., Julander A., Skare L., Thyssen J.P., Liden C. The cobalt spot test-further insights into its performance and use. Contact Dermatitis 2013, 69:280-287. (IIb).
253. Liden C., Skare L., Lind B., Nise G., Vahter M. Assessment of skin exposure to nickel, chromium and cobalt by acid wipe sampling and ICP-MS. Contact Dermatitis 2006, 54:233-238. (IIb).
254. Liden C., Skare L., Nise G., Vahter M. Deposition of nickel, chromium, and cobalt on the skin in some occupations-assessment by acid wipe sampling. Contact Dermatitis 2008, 58:347-354. (IIb).
255. Bourke J., Coulson I., English J. British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of contact dermatitis: an update. Br J Dermatol 2009, 160:946-954. (IV).
256. Diepgen T.L., Elsner P., Schliemann S., Fartasch M., Kollner A., Skudlik C., et al. Guideline on the management of hand eczema ICD-10 Code: L20, L23, L24, L25, L30. JDtsch Dermatol Ges 2009, 7(Suppl 3):S1-16. (IV).
257. Veien N.K., Olholm Larsen P., Thestrup-Pedersen K., Schou G. Long-term, intermittent treatment of chronic hand eczema with mometasone furoate. Br J Dermatol 1999, 140:882-886. (Ib).
258. Dooms-Goossens A., Pauwels M., Bourda A., Degreef H., Kinget R. Patch testing with corticosteroids in xerogel formulations. Contact Dermatitis 1992, 26:206-207.
259. Dooms-Goossens A., Morren M. Results of routine patch testing with corticosteroid series in 2073 patients. Contact Dermatitis 1992, 26:182-191.
260. Davis M.D., el-Azhary R.A., Farmer S.A. Results of patch testing to a corticosteroid series: a retrospective review of 1188 patients during 6 years at Mayo Clinic. JAm Acad Dermatol 2007, 56:921-927. (III).
261. Belsito D., Wilson D.C., Warshaw E., Fowler J., Ehrlich A., Anderson B., et al. Aprospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis. JAm Acad Dermatol 2006, 55:40-46. (IIb).
262. Meingassner J.G., Fahrngruber H., Bavandi A. Pimecrolimus inhibits the elicitation phase but does not suppress the sensitization phase in murine contact hypersensitivity, in contrast to tacrolimus and cyclosporine A. JInvest Dermatol 2003, 121:77-80. (IIb).
263. Amrol D., Keitel D., Hagaman D., Murray J. Topical pimecrolimus in the treatment of human allergic contact dermatitis. Ann Allergy Asthma Immunol 2003, 91:563-566. (IIa).
264. Granlund H., Erkko P., Reitamo S. Comparison of the influence of cyclosporine and topical betamethasone-17,21-dipropionate treatment on quality of life in chronic hand eczema. Acta Dermato-Venereol 1997, 77:54-58. (Ib).
265. Murphy G.M., Maurice P.D., Norris P.G., Morris R.W., Hawk J.L. Azathioprine treatment in chronic actinic dermatitis: a double-blind controlled trial with monitoring of exposure to ultraviolet radiation. Br J Dermatol 1989, 121:639-646. (Ib).
266. Rosen K., Mobacken H., Swanbeck G. Chronic eczematous dermatitis of the hands: a comparison of PUVA and UVB treatment. Acta Dermato-Venereol 1987, 67:48-54. (Ib).
267. van Gils R.F., Boot C.R., van Gils P.F., Bruynzeel D., Coenraads P.J., van Mechelen W., et al. Effectiveness of prevention programmes for hand dermatitis: a systematic review of the literature. Contact Dermatitis 2011, 64:63-72. (Ib).
268. Saary J., Qureshi R., Palda V., DeKoven J., Pratt M., Skotnicki-Grant S., et al. Asystematic review of contact dermatitis treatment and prevention. JAm Acad Dermatol 2005, 53:845. (Ib).
269. Emmett E.A. Dermatological screening. JOccup Med 1986, 28:1045-1050. (IV).
270. Dickel H., Kuss O., John S.M., Blome O., Hagemann K.H., Schwanitz H.J. Early secondary prevention of occupational skin disease in Germany: the dermatologist's procedure in perspective. Int Arch Occup Environ Health 2004, 77:142-149. (III).
271. Apfelbacher C.J., Soder S., Diepgen T.L., Weisshaar E. The impact of measures for secondary individual prevention of work-related skin diseases in health care workers: 1-year follow-up study. Contact Dermatitis 2009, 60:144-149. (III).
272. Wulfhorst B., Bock M., Gediga G., Skudlik C., Allmers H., John S.M. Sustainability of an interdisciplinary secondary prevention program for hairdressers. Int Arch Occup Environ Health 2010, 83:165-171. (III).
273. Cahill J., Nixon R. Allergic contact dermatitis to methylprednisolone aceponate in a topical corticosteroid. Aust J Dermatol 2004, 45:192-193.
274. Wall L.M., Gebauer K.A. Afollow-up study of occupational skin disease in Western Australia. Contact Dermatitis 1991, 24:241-243. (III).
275. Rosen R.H., Freeman S. Prognosis of occupational contact dermatitis in New South Wales, Australia. Contact Dermatitis 1993, 29:88-93. (III).
276. Cvetkovski R.S., Zachariae R., Jensen H., Olsen J., Johansen J.D., Agner T. Prognosis of occupational hand eczema: a follow-up study. Arch Dermatol 2006, 142:305-311. (III).
277. Malkonen T., Alanko K., Jolanki R., Luukkonen R., Aalto-Korte K., Lauerma A., et al. Long-term follow-up study of occupational hand eczema. Br J Dermatol 2010, 163:999-1006. (III).
278. Adisesh A., Meyer J.D., Cherry N.M. Prognosis and work absence due to occupational contact dermatitis. Contact Dermatitis 2002, 46:273-279.
279. Holness D.L. Workers with occupational contact dermatitis: work outcomes and return to work process in the first six months following diagnosis. JAllergy 2011, 2011:170693.
280. Holness D.L., Nethercott J.R. Work outcome in workers with occupational skin disease. Am J Indus Med 1995, 27:807-815.
281. Meding B., Lantto R., Lindahl G., Wrangsjo K., Bengtsson B. Occupational skin disease in Sweden-a 12-year follow-up. Contact Dermatitis 2005, 53:308-313.
282. Lau M.Y., Matheson M.C., Burgess J.A., Dharmage S.C., Nixon R. Disease severity and quality of life in a follow-up study of patients with occupational contact dermatitis. Contact Dermatitis 2011, 65:138-145.